NCT00549965View on ClinicalTrials.gov

Satisfaction and Compliance of Risedronate in PMO

PHASE4CompletedINTERVENTIONAL

Enrollment

202

Participants

Timeline

Start Date

October 31, 2003

Conditions

Osteoporosis, Postmenopausal

Interventions

DRUG

Risedronate Sodium

Trial Locations (1)

Unknown

Sanofi-Aventis, Daegu

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY